Harvard Medical School scientists have created a wirelessly programmed, miniaturized pacemaker which functions for weeks to months at a time, opening the door to “previously impossible investigations of arrhythmia and heart failure in the…

Preliminary results from the RETAKO trial, a study of takotsubo syndrome (TTS) in the Spanish population, have identified cardiogenic shock (CS) as an independent, strong predictor of mortality and complexities in TTS patients—a demographic that’…

Direct oral anticoagulants (DOACs) can cut the short-term risk of thromboembolic events in half for patients who have undergone cardioversion of atrial fibrillation (AFib), suggests a …

When cardiologists get involved in the treatment of patients with a history of cancer and newly diagnosed atrial fibrillation (AFib), those people see a subsequent 11 percent reduction in the risk of stroke, according to a new…

Digoxin, a cardiac glycoside popularly sold under the brand name Lanoxin, poses a major threat to the heart health of atrial fibrillation (AF) and heart failure (HF) patients, according to a…

The built-in electrocardiogram (EKG) feature of the Apple Watch Series 4 has been hailed as a major health innovation, gaining clearance from the FDA and drawing praise from the American Heart Association’s president during the product…

The long-held belief that sudden cardiac arrests (SCAs) occur most commonly on weekday mornings has been debunked by a team in Portland, Oregon, whose recent study of more than 1,500 SCA victims failed to identify any peak windows during which…

In patients with atrial fibrillation who have experienced MI or undergone percutaneous coronary intervention (PCI), treatment with a combination of direct oral anticoagulants (DOACs) and dual antiplatelet therapy (DAPT) could significantly…

Increases in tricuspid regurgitation (TR) severity occurred in 11.5 percent of patients following transvenous lead extraction, according to a single-center…

A patient’s odds of surviving out-of-hospital cardiac arrest (OHCA) fluctuate an average of 56 percent from one emergency medical services (EMS) agency to another, researchers reported Sept. 26 in …

OAC-ALONE, the first randomized trial to test the efficacy of oral anticoagulation (OAC) alone against combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AFib) and stable coronary artery disease, was unable…

A strict protocol mandating coronary angiography and therapeutic hypothermia contributed to “startling” improvements in survival rates for out-of-hospital cardiac arrest (OHCA), researchers reported in …

Atrial fibrillation patients are acutely aware of their five-fold increased risk of stroke, new research from StopAfib.org suggests—and 38 percent report feeling “trapped” between their fear of having a stroke and the major bleeding risks…

It’s well-known that automated external defibrillators (AEDs) can be a life-saving tool to treat cardiac arrhythmias, but a new study from the University of Washington (UW) underscores just how crucial accessible AEDs can be during…

The direct oral anticoagulant (DOAC) edoxaban is superior to warfarin for mitigating stroke risk in Latin American patients with atrial fibrillation (AFib), according to results of the ENGAGE AF-TIMI trial,…

Optimal candidates for a switch from vitamin K antagonists (VKAs) like warfarin to direct oral anticoagulants (DOACs) have long been identified by a single statistic—time-in-therapeutic range (TTR)—but a recent Danish analysis of anticoagulants…

French pharmaceutical company Servier has partnered with Bioserenity to launch a “smart T-shirt” they’re calling the Cardioskin—a wearable innovation that would allow heart patients to monitor their cardiac rhythm throughout the day, the Daily…

Scientists hope personalized data from patients experiencing irregular heartbeats will help improve accuracy in heart ablation procedures. The 3D simulations of 21 patients allow physicians to locate arrhythmia by “poking” the simulated heart…

The Apple Watch Series 4—the device’s first major update since its introduction to the market three years ago—will feature an electrocardiogram in addition to its existing heart rate monitor, the Verge reported this week.

The EKG is…

The majority of firefighters who die from cardiac arrest while on duty have underlying coronary heart disease (CHD) and an enlarged heart, including left ventricular hypertrophy, according to a…

A prevalence of left atrial fibrosis in endurance athletes could explain their increased risk for arrhythmias like atrial fibrillation (AFib), according to data presented this week at the European Society of Cardiology (ESC) Congress in Munich.…